Kini Vikram 4
4 · Ingersoll Rand Inc. · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
Ingersoll Rand CFO Vikram Kini Exercises Options, Sells Shares
What Happened
- Vikram Kini, Senior Vice President and Chief Financial Officer of Ingersoll Rand (IR), exercised two vested stock option grants on Feb 20, 2026 and immediately sold the resulting shares in the open market.
- He exercised 14,132 options at $11.43 per share (cost = $161,529) and 14,235 options at $32.06 per share (cost = $456,374), acquiring a total of 28,367 shares. Those 28,367 shares were sold in the open market at $96.50 per share for total proceeds of $2,737,416.
- The filing also shows corresponding derivative entries for the exercised options (zero-dollar disposals), which reflect the conversion/relinquishment of the option instruments upon exercise.
Key Details
- Transaction date: February 20, 2026.
- Exercises: 14,132 shares @ $11.43 (acquired, $161,529) and 14,235 shares @ $32.06 (acquired, $456,374).
- Sale: 28,367 shares @ $96.50 (disposed, $2,737,416).
- Footnote: Options exercised were fully vested and exercisable.
- Shares owned after the transaction: not specified in the provided filing excerpt.
- Filing: Reported on Feb 23, 2026; the filing does not indicate a late-report flag in the provided data.
Context
- This pattern—exercising vested options and immediately selling the acquired shares—is commonly a cashless exercise/sale to realize option value and cover exercise costs or taxes. The filing is factual and does not state the insider's motivation.
- For retail investors, purchases signal a direct buy of company stock; here the notable activity is a sale following option exercise, which is often routine compensation-related liquidity rather than a clear statement of sentiment.
Insider Transaction Report
Form 4
Kini Vikram
Senior Vice President and CFO
Transactions
- Exercise/Conversion
Common Stock
2026-02-20$11.43/sh+14,132$161,529→ 112,649 total - Exercise/Conversion
Common Stock
2026-02-20$32.06/sh+14,235$456,374→ 126,884 total - Sale
Common Stock
2026-02-20$96.50/sh−28,367$2,737,416→ 98,517 total - Exercise/Conversion
Stock Options (Right to Buy)
[F1]2026-02-20−14,132→ 0 totalExercise: $11.43Exp: 2026-12-09→ Common Stock (14,132 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
[F1]2026-02-20−14,235→ 0 totalExercise: $32.06Exp: 2028-02-22→ Common Stock (14,235 underlying)
Footnotes (1)
- [F1]These stock options are fully vested and exercisable.
Signature
/s/ Andrew Schiesl, as Attorney-in-Fact|2026-02-23